A. A. Daffada

Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction.

M. Dowsett, S. Johnston, A. Daffada, 1994, Journal of molecular endocrinology.

Oestrogen receptor mutants and variants in breast cancer.

M. Dowsett, S. Johnston, S. Johnston, 1997, European journal of cancer.

Tissue-dependent expression of a novel splice variant of the human oestrogen receptor

M. Dowsett, A. Daffada, A. A. Daffada, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Exon S Deletion Variant Estrogen Receptor Messenger RNA Expression in Relation to Tamoxifen Resistance and Progesterone Receptor / pS 2 Status in Human Breast Cancer '

I. Smith, Nicholas, Dowsett, 2022 .

Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer.

M. Dowsett, I. Smith, S. Johnston, 1995, Cancer research.

Control of activator protein-1 and nuclear factor kappa B activity by interleukin-1, interleukin-6 and metals in HEPG2 cells.

S. Young, E. Murray, A. Daffada, 1994, Biochimica et biophysica acta.

Coordinated regulation of ceruloplasmin and metallothionein mRNA by interleukin‐1 and copper in HepG2 cells

S. Young, A. Daffada, A. A. Daffada, 1999, FEBS letters.

Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer

M. Dowsett, Christina M.W. Chan, Xiang-Qian Zhu, 1997, International journal of cancer.